Consun Pharmaceutical Group Ltd. (HK:1681) has released an update.
Consun Pharmaceutical Group Ltd. has appointed Professor Li Yikai as an independent non-executive director, as well as the chairman of the nomination committee and a member of the audit committee, effective from June 21, 2024. With extensive experience in traditional Chinese medicine and a notable academic and professional background, Professor Li’s appointment brings the number of independent non-executive directors on the board back to the required minimum, ensuring compliance with Hong Kong Stock Exchange rules.
For further insights into HK:1681 stock, check out TipRanks’ Stock Analysis page.
